Dr. Lal Path Labs Ltd. — Board Meeting, 31-07-2025: Outcome of Board Meeting

Dr. Lal PathLabs has announced key outcomes from its recent board meeting. The company approved the financial results for Q1, reporting consolidated revenue of ₹61.70 Cr and profit of ₹13.40 Cr. This indicates continued operational performance for investors. An interim dividend of ₹6 per equity share for FY26 was declared, offering direct returns to shareholders. The board also strengthened its governance by amending its code for fair disclosure of Unpublished Price Sensitive Information, improving transparency practices.